EcoDrugPlus

Cyclin Dependent Kinase 5

Ensembl ID : ENSCMIG00000006651
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSCMIG00000016624
Gene Symbol: CDK6
3 Cross references
128 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSCMIG00000018767
Gene Symbol: CDK7
4 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSCMIG00000014543
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSCMIG00000007744
Gene Symbol: CYSLTR1
4 Cross references
181 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSCMIG00000018669
Gene Symbol: CDA
4 Cross references
232 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSCMIG00000018297
Gene Symbol: LOC103180634
3 Cross references
208 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSCMIG00000003198
Gene Symbol: DGAT1
3 Cross references
264 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSCMIG00000014663
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSCMIG00000004966
Gene Symbol: DPYD
4 Cross references
231 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSCMIG00000018920
Gene Symbol: DDR2
4 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCMIG00000012218
Gene Symbol: DRD1
3 Cross references
262 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).